These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9717974)

  • 1. A vigorous virus-specific CD4+ T cell response may contribute to the association of HLA-DR13 with viral clearance in hepatitis B.
    Diepolder HM; Jung MC; Keller E; Schraut W; Gerlach JT; Grüner N; Zachoval R; Hoffmann RM; Schirren CA; Scholz S; Pape GR
    Clin Exp Immunol; 1998 Aug; 113(2):244-51. PubMed ID: 9717974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of HLA DR13-restricted CD4(+) T cell epitopes of hepatitis B core antigen associated with self-limited, acute hepatitis B.
    Cao T; Desombere I; Vanlandschoot P; Sällberg M; Leroux-Roels G
    J Gen Virol; 2002 Dec; 83(Pt 12):3023-3033. PubMed ID: 12466479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-A31- and HLA-Aw68-restricted cytotoxic T cell responses to a single hepatitis B virus nucleocapsid epitope during acute viral hepatitis.
    Missale G; Redeker A; Person J; Fowler P; Guilhot S; Schlicht HJ; Ferrari C; Chisari FV
    J Exp Med; 1993 Mar; 177(3):751-62. PubMed ID: 7679709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo inhibition of anti-hepatitis B virus core antigen (HBcAg) immunoglobulin G production by HBcAg-specific CD4(+) Th1-type T-cell clones in a hu-PBL-NOD/SCID mouse model.
    Cao T; Meuleman P; Desombere I; Sällberg M; Leroux-Roels G
    J Virol; 2001 Dec; 75(23):11449-56. PubMed ID: 11689626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct evidence that naturally occurring mutations within hepatitis B core epitope alter CD4+ T-cell reactivity.
    Torre F; Cramp M; Owsianka A; Dornan E; Marsden H; Carman W; Williams R; Naoumov NV
    J Med Virol; 2004 Mar; 72(3):370-6. PubMed ID: 14748060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection.
    Diepolder HM; Gerlach JT; Zachoval R; Hoffmann RM; Jung MC; Wierenga EA; Scholz S; Santantonio T; Houghton M; Southwood S; Sette A; Pape GR
    J Virol; 1997 Aug; 71(8):6011-9. PubMed ID: 9223492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness.
    Godkin A; Davenport M; Hill AV
    Hepatology; 2005 Jun; 41(6):1383-90. PubMed ID: 15915462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different levels of T-cell receptor triggering induce distinct functions in hepatitis B and hepatitis C virus-specific human CD4(+) T-cell clones.
    Diepolder HM; Gruener NH; Gerlach JT; Jung MC; Wierenga EA; Pape GR
    J Virol; 2001 Sep; 75(17):7803-10. PubMed ID: 11483723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8
    Zhang Y; Wu Y; Deng M; Xu D; Li X; Xu Z; Hu J; Zhang H; Liu K; Zhao Y; Gao F; Bi S; Gao GF; Zhao J; Liu WJ; Meng S
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29950410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anergic TH1 clones specific for hepatitis B virus (HBV) core peptides are inhibitory to other HBV core-specific CD4+ T cells in vitro.
    Diepolder HM; Jung MC; Wierenga E; Hoffmann RM; Zachoval R; Gerlach TJ; Scholz S; Heavner G; Riethmüller G; Pape GR
    J Virol; 1996 Nov; 70(11):7540-8. PubMed ID: 8892873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficient presentation of known HLA class II-restricted MAGE-A3 epitopes by dendritic cells electroporated with messenger RNA encoding an invariant chain with genetic exchange of class II-associated invariant chain peptide.
    Bonehill A; Heirman C; Tuyaerts S; Michiels A; Zhang Y; van der Bruggen P; Thielemans K
    Cancer Res; 2003 Sep; 63(17):5587-94. PubMed ID: 14500399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of twenty peptides representing epitopes of the hepatitis B core and surface antigens by IFN-γ response in chronic and resolved HBV.
    Brinck-Jensen NS; Vorup-Jensen T; Leutscher PD; Erikstrup C; Petersen E
    BMC Immunol; 2015 Nov; 16():65. PubMed ID: 26526193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Minimal T-cell-stimulatory sequences and spectrum of HLA restriction of immunodominant CD4+ T-cell epitopes within hepatitis C virus NS3 and NS4 proteins.
    Gerlach JT; Ulsenheimer A; Grüner NH; Jung MC; Schraut W; Schirren CA; Heeg M; Scholz S; Witter K; Zahn R; Vogler A; Zachoval R; Pape GR; Diepolder HM
    J Virol; 2005 Oct; 79(19):12425-33. PubMed ID: 16160170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes.
    Chaux P; Vantomme V; Stroobant V; Thielemans K; Corthals J; Luiten R; Eggermont AM; Boon T; van der Bruggen P
    J Exp Med; 1999 Mar; 189(5):767-78. PubMed ID: 10049940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytotoxic T lymphocytes recognize an HLA-A2-restricted epitope within the hepatitis B virus nucleocapsid antigen.
    Penna A; Chisari FV; Bertoletti A; Missale G; Fowler P; Giuberti T; Fiaccadori F; Ferrari C
    J Exp Med; 1991 Dec; 174(6):1565-70. PubMed ID: 1720813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic T lymphocyte response to a wild type hepatitis B virus epitope in patients chronically infected by variant viruses carrying substitutions within the epitope.
    Bertoletti A; Costanzo A; Chisari FV; Levrero M; Artini M; Sette A; Penna A; Giuberti T; Fiaccadori F; Ferrari C
    J Exp Med; 1994 Sep; 180(3):933-43. PubMed ID: 7520476
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between hepatitis B virus infection and HLA-DR type in Korea.
    Ahn SH; Han KH; Park JY; Lee CK; Kang SW; Chon CY; Kim YS; Park K; Kim DK; Moon YM
    Hepatology; 2000 Jun; 31(6):1371-3. PubMed ID: 10827165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
    J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute phase HBV-specific T cell responses associated with HBV persistence after HBV/HCV coinfection.
    Urbani S; Boni C; Amadei B; Fisicaro P; Cerioni S; Valli MA; Missale G; Ferrari C
    Hepatology; 2005 Apr; 41(4):826-31. PubMed ID: 15726541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hepatitis B virus-specific CTL epitopes presented by HLA-A*2402, the most common HLA class I allele in East Asia.
    Sobao Y; Sugi K; Tomiyama H; Saito S; Fujiyama S; Morimoto M; Hasuike S; Tsubouchi H; Tanaka K; Takiguch M
    J Hepatol; 2001 Jun; 34(6):922-9. PubMed ID: 11451178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.